ClinicalTrials.Veeva

Menu

Global Impact of COVID-19 on Pulmonology Special Units

A

Assiut University

Status

Unknown

Conditions

Global Impact
Covid19
Pulmonology

Treatments

Other: Survey

Study type

Observational

Funder types

Other

Identifiers

NCT04554251
Assiut20

Details and patient eligibility

About

The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there were 4,889,287 confirmed cases and 322,683 deaths globally. The healthcare system is wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously confronting an unprecedented reduction in elective and non-essential care.

A survey by the American Cancer Society showed that 50% of cancer patients and survivors reported some impact to their healthcare due to the COVID-19 epidemic.

A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy practices in North America.

However, the impact of this epidemic on Pulmonology units ( bronchoscopy, thoracoscopy, ultrsonography and sleep lab) globally has not been studied.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Working registered invited pulmonology units; governmental, university, private

Exclusion criteria

  • non pulmonary medicine registered units

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems